INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE COTE D'AZUR FILES APPLICATION FOR "THERAPEUTIC USE OF STING AND TLRS AGONISTS TO INDUCE P16 EXPRESSION IN IMMUNE CELLS"

GENEVA, Oct. 4 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 PARIS), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (3 rue Michel Ange75016 PARIS), UNIVERSITE COTE D'AZUR (Grand Chateau - 28, Avenue de Valrose06103 NICE) filed a patent application (PCT/EP2025/058170) for "THERAPEUTIC USE OF STING AND TLRS AGONISTS TO INDUCE P16 EXPRESSION IN IMMUNE CELLS" on Mar 25, 2025. With publication no. WO/2025/202222, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): POLSKI, Barbara (CHU de Nice ...